Advertisement

Topics

5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500

13:01 EDT 14 Mar 2018 | BioPortfolio Report Blog

5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 Pipeline Review, H1 2018


Summary


5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 pipeline Target constitutes close to 21 molecules. Out of which approximately 20 molecules are developed by companies and remaining by the universities/institutes. The latest report 5Hydroxytryptamine Receptor 6 Pipeline Review, H1 2018, outlays comprehensive information on the 5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type.


5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 The 5HT6 receptor is a subtype of 5HT receptor that binds the endogenous neurotransmitter serotonin. Blockade of 5HT6 receptors showed to increase glutamatergic and cholinergic neurotransmission in brain, whereas activation enhances GABAergic signaling in a widespread manner.


Antagonism of 5HT6 receptors facilitates dopamine and norepinephrine release in the frontal cortex while stimulation has the opposite effect. 5HT6 receptor plays an important role in Alzheimer's disease and other forms of dementia and obesity. The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 3, 2, 11 and 2 respectively.


Similarly, the universities portfolio in Preclinical stages comprises 1 molecule, respectively. Report covers products from therapy areas Central Nervous System, Cardiovascular and Metabolic Disorders which include indications Schizophrenia, Alzheimer's Disease, Psychiatric Disorders, Anxiety Disorders, Cognitive Disorders, Mild Cognitive Impairment, Attention Deficit Hyperactivity Disorder ADHD, Bipolar Disorder Manic Depression, Dementia, Dementia Associated With Alzheimer's Disease, Depression, Major Depressive Disorder, Neurology, Obesity, Parkinson's Disease, Pervasive Developmental Disorder PDD, Psychosis, Pulmonary Arterial Hypertension, Schizoaffective Disorder and Tourette Syndrome.


Furthermore, this report also reviews key players involved in 5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The report provides a snapshot of the global therapeutic landscape for 5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6

The report reviews 5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources

The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities

The report reviews key players involved in 5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 targeted therapeutics and enlists all their major and minor projects

The report assesses 5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to 5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 targeted therapeutics


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for 5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding 5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 development landscape

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Original Article: 5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "5Hydroxytryptamine Receptor 6 5 HT6 or Serotonin Receptor 6 or HTR6 Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Selective serotonin reuptake inhibitors SSRIs
Serotonin and norepinephrine reuptake inhibitors (SNRIs) are a class of medications that are effective at easing depression symptoms. SNRIs are also sometimes used to treat other conditions such as anxiety and nerve pain. How SNRIs work Serotonin (se...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Dementia
Dementia describes a range of symptoms of cognitive decline. For example memory loss, problems with reasoning and communication skills, and a reduction in a person's abilities and skills in carrying out daily activities. There are about 820,000 peo...